- NCIt
- C40283
Loading cancer entity…
Loading cancer entity…
Clinical trials
57 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07804966 | Sac-TMT in Vaginal and Vulvar Cancers(ARCANA) | not yet recruiting | Phase 2 | 48 | Latin American Cooperative Oncology GroupOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07793552 | Needlefree Lidocaine Application for Vulvar Biopsies | not yet recruiting | N/A | 106 | Tufts Medical CenterOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07679841 |
| Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients(COLOMBE) |
| not yet recruiting |
| Phase 1 / Phase 2 |
| 50 |
| Centre Leon BerardOTHER |
| 1 |
| Jul 1, 2026 |
| clinicaltrials |
| NCT06911801 | In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer(FAPI_VULVA_1) | not yet recruiting | — | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06505551 | Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma | not yet recruiting | Phase 1 / Phase 2 | 66 | SCG Cell Therapy Pte. Ltd.INDUSTRY | 0 | Jul 17, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Sep 4, 2026source: clinicaltrials